Description

Mofilet 500mg Tablets: A Comprehensive Overview

Mofilet 500mg Tablets contain Mycophenolate Mofetil (MMF), a potent immunosuppressant drug. Doctors use this medication primarily to prevent the body from rejecting a transplanted organ, specifically a transplanted kidney, heart, or liver. Mycophenolate Mofetil is a prodrug that is rapidly converted to its active form, Mycophenolic Acid (MPA). MPA works by a specific mechanism: it selectively and reversibly inhibits inosine monophosphate dehydrogenase (IMPDH). This enzyme is crucial for the de novo synthesis of guanosine nucleotides, which are essential building blocks for DNA and RNA. Lymphocytes (T and B cells) are heavily dependent on this de novo pathway for proliferation. Consequently, by inhibiting this pathway, MPA effectively weakens the immune response, preventing the rapid division and activity of the lymphocytes responsible for organ rejection.

Usage, Administration, and Therapeutic Protocols

This medication is almost always used in combination with other immunosuppressants, such as cyclosporine and corticosteroids. This multi-drug approach minimizes toxicity while maximizing immunosuppressive efficacy. Mofilet helps maintain the long-term function of the transplanted organ and significantly reduces the risk of rejection complications. A patient must take the tablets orally exactly as advised by a healthcare professional, typically twice daily. Consistent adherence is critical because any lapse in dosing can rapidly lead to organ rejection. The exact dosage is highly individualized and depends on the type of transplant and the patient’s co-administered therapies.

Manufacturing, Safety, and Monitoring

Emcure Pharmaceuticals manufactures Mofilet 500mg Tablets. It is widely prescribed in transplant management. While essential for graft survival, a patient may experience some side effects. Common adverse effects may include nausea, vomiting, diarrhea (which can be dose-limiting), and a significant increased risk of infection due to the overall immunosuppression. Furthermore, the drug can cause leucopenia (low white blood cell count). For this reason, doctors consider regular monitoring of complete blood counts and vigilant assessment for signs of infection essential throughout the treatment.

Availability & Purchase Information

Genetec Lifesciences makes Mofilet Mycophenolate 500mg Tablets available. All medicines are sourced directly from Emcure or its authorized vendors.

Disclaimer

This site provides product information for informative purposes only. The product image belongs to its respective company. Genetec Lifesciences acts as a wholesaler and distributor, not a manufacturer. We source our medicines directly from the company or authorized vendors of the company.